Terug
Dagbereik
€ 31,85
€ 33,93
52-Weeksbereik
€ 5,35
€ 40,22
Volume
409.419
50D / 200D Gem.
€ 32,73
/
€ 24,99
Vorige Slotkoers
€ 33,40
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -276,5 | 0,3 |
| P/B | 5,4 | 2,9 |
| ROE % | -2,4 | 3,7 |
| Net Margin % | -3,7 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 42,75
+32.8%
Low: € 35,00
High: € 60,00
Forward WPA
-€ 3,38
Omzet Sch.
27 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,08
€ 0,00 – € 0,18
|
340 M | 6 |
| FY2028 |
-€ 2,15
-€ 3,43 – -€ 0,69
|
120 M | 8 |
| FY2027 |
-€ 3,16
-€ 3,77 – -€ 2,05
|
49 M | 9 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Generating 44,92M in free cash flow
Capital efficient — spends only 0,36% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)404,50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-2,37%
ROIC-4,38%
Net Margin-3,73%
Op. Margin-11,16%
Veiligheid
Debt / Equity
0,00
Current Ratio5,28
Interest Coverage-1,50
Waardering
P/E Ratio
-276,47
P/B Ratio5,40
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 404,50% | Revenue Growth (3Y) | 358,31% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 184,42M | Net Income (TTM) | -6,89M |
| ROE | -2,37% | ROA | -1,65% |
| Gross Margin | 100,00% | Operating Margin | -11,16% |
| Net Margin | -3,73% | Free Cash Flow (TTM) | 44,92M |
| ROIC | -4,38% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 5,28 |
| Interest Coverage | -1,50 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -276,47 | P/B Ratio | 5,40 |
| P/S Ratio | 10,32 | PEG Ratio | 2,94 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,90B | Enterprise Value | 1,82B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 184,42M | 36,56M | 8,78M | 12,41M | 0,0 |
| Net Income | -6,89M | -88,98M | -104,70M | -101,07M | -85,81M |
| EPS (Diluted) | -0,12 | -1,65 | -2,38 | -2,60 | -2,34 |
| Gross Profit | 184,42M | 36,56M | 8,78M | 12,41M | 0,0 |
| Operating Income | -20,59M | -101,37M | -114,77M | -104,36M | -86,07M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 418,43M | 271,56M | 228,34M | 256,07M | 238,87M |
| Total Liabilities | 65,98M | 42,53M | 68,78M | 71,22M | 21,09M |
| Shareholders' Equity | 352,46M | 229,02M | 159,57M | 184,85M | 217,78M |
| Total Debt | 0,0 | 2,32M | 2,06M | 2,36M | 1,51M |
| Cash & Equivalents | 84,22M | 127,98M | 191,44M | 113,56M | 144,90M |
| Current Assets | 305,70M | 232,76M | 215,34M | 244,07M | 229,22M |
| Current Liabilities | 57,88M | 40,06M | 30,82M | 31,39M | 17,14M |